Die Bedeutung des Koloniebildungstestes beim Ovarialkarzinom
- 1 January 1984
- journal article
- research article
- Published by S. Karger AG in Oncology Research and Treatment
- Vol. 7 (2) , 66-73
- https://doi.org/10.1159/000215518
Abstract
Methods and evaluation of the human tumor stem cell assay (HTSCA) are described. Advantages and disadvantages of the test system are elaborated. The in vitro/in vivo correlation in the drug screening of human ovarian carcinomas shows that the prediction of sensitivity to a cytotoxic agent is only possible in 64%. Prediction of drug resistance seems to be possible in 95%. The number of patients that profit from the HTSCA seems to be only < 10%. The investigations describe the influence of various hormones and antiestrogens on the colony formation of human ovarian carcinoma cells. Tamoxifen and its major metabolite 4-hydroxy-tamoxifen were the most active agents. Both compounds inhibit the colony survival (70% at pharmacological concentrations) of 60% of the screened ovarian carcinomas. A significant correlation to the quantitative level of estrogen or progesterone receptors could not be proved. Colony formation of ovarian carcinoma cells was compared in the HTSCA as described by Hamburger and Salmon and in a methylcellulose-monolayer system. The colony formation corresponds to the results of the original HTSCA. Cloning ovarian carcinoma cells in the methylcellulose-monolayer seems to be technically eaiser and faster.This publication has 19 references indexed in Scilit:
- Time-Dependent Changes in Drug Sensitivity Expressed by Mammalian Cells After Exposure to Trypsin2JNCI Journal of the National Cancer Institute, 1980
- CLONING OF HUMAN OVARIAN-CANCER CELLS IN SOFT AGAR FROM MALIGNANT EFFUSIONS AND PERITONEAL WASHINGS1980
- Pharmacokinetic Approach to in vitro Testing of Ovarian Cancer Cell SensitivityOncology, 1980
- METHODOLOGICAL APPROACH TO THE PREDICTION OF ANTI-CANCER DRUG EFFECT IN HUMANS1979
- DIRECT CLONING OF HUMAN OVARIAN CARCINOMA CELLS IN AGAR1978
- On receptors for estrogens (e2) and androgens (dht) in human endometrial carcinoma and ovarian tumoursActa Obstetricia et Gynecologica Scandinavica, 1978
- Primary Bioassay of Human Myeloma Stem CellsJournal of Clinical Investigation, 1977
- MEDROXYPROGESTERONE ACETATE FOR TREATMENT OF METASTATIC AND RECURRENT OVARIAN CARCINOMA1977
- A RAPID METHOD FOR VIABLE CELL TITRATION AND CLONE PRODUCTION WITH HELA CELLS IN TISSUE CULTURE: THE USE OF X-IRRADIATED CELLS TO SUPPLY CONDITIONING FACTORSProceedings of the National Academy of Sciences, 1955
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951